4/A
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-22-036711
Chief Business Officer gave up 1,102 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Boyle Scott N Chief Business Officer | 2022-05-26 | Shares withheld for taxes | −1,102 | $7.01 | $7,725 | 2,648 | D |
Loading xslF345X03/doc4a.xml…